John C. Byrd, MD

University of Cincinnati College of Medicine
Cincinnati, OH, United States

N/A

Presentation(s):

• (1546705) The PKCβ inhibitor MS-553 displays preclinical efficacy in BTK inhibitor resistant Chronic Lymphocytic Leukemia

  Friday, October 6, 2023
  11:25 AM – 11:30 AM EDT

• (1549556) Bruton’s Tyrosine Kinase and Phospholipase C-Gamma 2 Mutational Profiles in Pooled Analysis of Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

  Sunday, October 8, 2023
  12:05 PM – 12:15 PM EDT